Zaloguj się

Gotowe bibliografie tematyczne / Sickle cells diseases / Książki

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Sickle cells diseases.

Książki na temat „Sickle cells diseases”

Autor: Grafiati

Data publikacji: 12 kwietnia 2025

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych książek naukowych na temat „Sickle cells diseases”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj książki z różnych dziedzin i twórz odpowiednie bibliografie.

1

Alvin, Silverstein, Silverstein Virginia B i Nunn Laura Silverstein, red. What you can do about sickle cell disease. New York, NY: Enslow Publishing, 2016.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

2

Peak, Lizabeth. Sickle cell disease. Detroit: Lucent Books, 2008.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

3

Peak, Lizabeth. Sickle cell disease. Detroit: Lucent Books, 2008.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

4

Serjeant, Graham R. Sickle cell disease. Wyd. 2. Oxford: Oxford University Press, 1992.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

5

F, Whitten Charles, Bertles John F. 1925-, National Association for Sickle Cell Disease (U.S.) i New York Academy of Sciences., red. Sickle cell disease. New York, N.Y: New York Academy of Sciences, 1989.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

6

Eboh, Winifred Oluchukwu. Sickle cell disease. (Birmingham): Birmingham Sickle Cell & Thalassaemia Centre, 1993.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

7

Jones, Phill. Sickle cell disease. New York: Chelsea House, 2008.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

8

Samuel, Charache, i Johnson Cage S, red. Sickle cell disease. Philadelphia: W.B. Saunders, 1996.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

9

McCormick, Marie, Henrietta Awo Osei-Anto i Rose Marie Martinez, red. Addressing Sickle Cell Disease. Washington, D.C.: National Academies Press, 2020. http://dx.doi.org/10.17226/25632.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

10

Beshore, George. Sickle cell anemia. New York: F. Watts, 1994.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

11

P, Rodgers Griffin, red. Sickle cell disease and thalassaemia. London: Baillière Tindall, 1998.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

12

author, Chilman-Blair Kim, i DeLoache Shawn author, red. Medikidz explain sickle cell disease. London: Medikidz Ltd., 2013.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

13

Howard, Jo, i Paul Telfer. Sickle Cell Disease in Clinical Practice. London: Springer London, 2015. http://dx.doi.org/10.1007/978-1-4471-2473-3.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

14

National Heart, Lung, and Blood Institute. Division of Blood Diseases and Resources., red. The Management of sickle cell disease. Wyd. 4. Bethesda, MD: The Institute, 2002.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

15

National Heart, Lung, and Blood Institute. Division of Blood Diseases and Resources. The management of sickle cell disease. Wyd. 4. Bethesda, MD: The Institute, 2002.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

16

Midence, Kenny. Sickle cell disease: A psychosocial approach. Oxford: Radcliffe Medical Press, 1994.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

17

Meier, Emily Riehm, Allistair Abraham i Ross M. Fasano, red. Sickle Cell Disease and Hematopoietic Stem Cell Transplantation. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-62328-3.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

18

1932-, Hurtig Anita Landau, i Viera Carol Therese 1952-, red. Sickle cell disease: Psychological and psychosocial issues. Urbana: University of Illinois Press, 1986.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

19

N, Mankad Vipul, i Moore R. Blaine, red. Sickle cell disease: Pathophysiology, diagnosis, and management. Westport, Conn: Praeger, 1992.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

20

Ennis, Sylvia. The natural choice: Sickle cell disease/ thalassaemia. New Delhi: B.Jain Publishers, 1994.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

21

Anionwu, Elizabeth N. Sickle cell disease: A guide for families. Harlow: Longman, 1991.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

22

Samuel, Charache, Lubin Bertram, Reid Clarice D, United States. Dept. of Health and Human Services., National Institutes of Health (U.S.) i United States. Public Health Service., red. Management and therapy of sickle cell disease. Wyd. 3. [Bethesda, Md.]: U. S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Heart, Lung, and Blood Institute, 1995.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

23

Inusa, Baba, Kanayo Nwankwo, Nkechikwu Azinge-Egbiri i Bukola Bolarinwa. Sickle Cell Disease in Sub-Saharan Africa. London: Routledge, 2024. http://dx.doi.org/10.4324/9781003463931.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

24

Inusa, Baba, Kanayo Nwankwo, Nkechikwu Azinge-Egbiri i Bukola Bolarinwa. Sickle Cell Disease in Sub-Saharan Africa. London: Routledge, 2024. http://dx.doi.org/10.4324/9781003467748.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

25

D, O'Malley Paul, red. New developments in sickle cell disease research. New York: Nova Science Publishers, 2006.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

26

B, Jibril Harun, red. Sickle cell disease: A guide for families. London: Collins, 1986.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

27

Al-Jamʼa, Ali H. Management manual of sickel cell disease. [Saudi Arabia: Qatif Central Hospital], 1992.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

28

Rosse, Wendell F. Transfusion support for patients with sickle cell disease. Bethesda, Md: AABB Press, 1998.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

29

Ng, Ann, i Erin S. Williams. Sickle Cell Disease. Redaktorzy Erin S. Williams, Olutoyin A. Olutoye, Catherine P. Seipel i Titilopemi A. O. Aina. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190678333.003.0033.

Pełny tekst źródła

Streszczenie:

Sickle cell anemia (sickle cell disease) is a common hemoglobinopathy with anywhere from 90,000 to 100,000 Americans affected. This chronic condition has a predominance in populations of African descent, occurring in approximately 1 out of 365 African American births, compared to 1 out of 16,300 Hispanic births. The sickle cell trait can be detected in 1 of 13 African American births. One of the most common complications associated with sickle cell anemia, vaso-occlusive crises by sickled cells, results in severe pain. Other issues associated with this condition include acute chest syndrome, lung infections, end organ damage, and stroke. With improvements in the management and prevention of pain crises, infection, and other systemic involvement, these patients are living longer, thus increasing the potential for surgical needs. Whether it is for routine surgeries or surgeries that are due to the natural history of the disease; the pediatric anesthesiologist must be knowledgeable of the management of these patients in order to prevent morbidity and mortality.

Style APA, Harvard, Vancouver, ISO itp.

30

Sickle Cell Disease (Diseases and Disorders). Lucent Books, 2007.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

31

Vescia, Monique, i Virginia Silverstein. What You Can Do about Sickle Cell Disease. Enslow Publishing, LLC, 2015.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

32

Szabova, Alexandra, i Kenneth R. Goldschneider. Sickle Cell Disease. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199764495.003.0040.

Pełny tekst źródła

Streszczenie:

0.2% of African-Americans have sickle cell anemia while, with 8% to 10% have sickle cell trait. This chapter provides an overiew of the etiology, pathophysiology, and treatment of sickle cell anemia as they affect anesthetic management—before, during, and after surgery.

Style APA, Harvard, Vancouver, ISO itp.

33

Serjeant, Graham R. Sickle Cell Disease. Oxford University Press, USA, 1988.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

34

Anionwu, Elizabeth, i H. Jibril. Sickle Cell Disease. Longman, 1986.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

35

Franklin, Andrew. Sickle Cell Disease. Redaktorzy Matthew D. McEvoy i Cory M. Furse. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190226459.003.0084.

Pełny tekst źródła

Streszczenie:

Sickle cell disease, a hemoglobinopathy that affects multiple organ systems, is a complex disease entity that presents unique challenges during the perioperative period. The hallmark of sickle cell disease, vaso-occlusion, results from sickling of erythrocytes containing hemoglobin of abnormal conformation due to genetically mutated beta globin genes. The perioperative clinician must properly care for acute sickle cell crises including acute painful episodes and acute chest syndrome, and safely care for the sickle cell patient through the preoperative, intraoperative, and postoperative phases of surgical treatment. Both acute painful episodes and acute chest syndrome result from vaso-occlusive crises, and early stabilization of these emergencies is crucial to ensuring a positive patient outcome. The singular perioperative objective for the care of sickle cell disease patients is both simple and daunting: to achieve physiologic homeostasis in patients with preexisting multiorgan dysfunction undergoing a series of physiologic insults during and after surgery.

Style APA, Harvard, Vancouver, ISO itp.

36

Ferrari, Lynne R. Sickle Cell Disease. Redaktorzy Kirk Lalwani, Ira Todd Cohen, Ellen Y. Choi i Vidya T. Raman. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190685157.003.0051.

Pełny tekst źródła

Streszczenie:

Sickle cell anemia is a disease that combines molecular biology, clinical features, biochemistry, pathology, natural selection, population genetics, gene expression, and genomics and is the world’s most common life-threatening monogenic disorder. Clinical features include anemia; painful crisis especially in fingers, chest, and long bones; hemolysis; splenic infarction resulting in functional asplenia; and microinfarction leading to neurologic and renal impairment. The maintenance of adequate body temperature with active warming devices and warmed intravenous fluids, monitoring hydration and urine output, providing supplemental oxygen, and limiting surgical and anesthesia times to reduce pulmonary complications constitute the best management for patients with sickle cell disease.

Style APA, Harvard, Vancouver, ISO itp.

37

Anionwu, Elizabeth, i H. Jibril. Sickle Cell Disease. Wyd. 2. Longman, 1992.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

38

Sickle cell disease. Wyd. 2. Oxford: Oxford University Press, 1992.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

39

Erhabor, Osaro. Sickle Cell Disease. IntechOpen, 2022.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

40

Sickle cell disease. Oxford: Oxford University Press, 1985.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

41

Gladwin, Mark T., Gregory J. Kato i Enrico M. Novelli. Sickle Cell Disease. McGraw-Hill Education, 2021.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

42

Alebiosu, Christopher Olutayo. Sickle Cell Disease. Cambridge Scholars Publishing, 2020.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

43

Midence, Kenny. Sickle Cell Disease. Scovill-Paterson, 1994.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

44

Batchelor, Tracy, Joshua P. Klein, Andrés José María Ferreri i Lisa M. DeAngelis, red. Oxford Textbook of Neurohaematology. Oxford University PressOxford, 2024. http://dx.doi.org/10.1093/med/9780198884903.001.0001.

Pełny tekst źródła

Streszczenie:

Abstract The Oxford Textbook of Neurohaematology is the first dedicated source of knowledge on the diverse neurological conditions associated with malignant and classical haematological diseases. The book is divided into three sections. In the first section, neurological conditions associated with malignant haematological diseases are covered. This section begins with chapters on primary haematological malignancies of the nervous system, including primary central nervous system lymphomas, vitreoretinal lymphoma, and other rare primary malignancies such as Hodgkin disease and lymphoproliferative disorders. Next, a chapter on histiocytic tumours of the central nervous system presents the neurological conditions associated with the Langerhans and non-Langerhans histiocytoses. This is followed by chapters covering the neurological complications of systemic myeloid and lymphoid malignancies. The second section of the book covers neurological complications of treatments used in the management of haematological malignancies such as chemotherapy, radiation, and immunotherapy, including chimeric antigen receptor T cells. The third and final section of the book features chapters on neurological complications associated with classical haematological diseases, including disorders of red blood cells (e.g. sickle cell anaemia), disorders of platelets and coagulation (e.g. immune thrombocytopenia), and disorders of white blood cells (e.g. hyperviscosity syndrome).

Style APA, Harvard, Vancouver, ISO itp.

45

Lance, Eboni I., i Andrew W. Zimmerman. Sickle Cell Anemia. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199937837.003.0079.

Pełny tekst źródła

Streszczenie:

Sickle cell disease is a genetic hematological disorder involving red blood cells that become deformed when stressed. Patients with homozygous hemoglobin SS disease often have multiple systemic and neurologic complications, particularly stroke. Intellectual disability is commonly seen in the population, in patients with and without a history of stroke, attributed to different underlying mechanisms of brain injury. Autism is rare and not described in sickle cell disease in the literature to date. Many treatments (chronic transfusion therapy, hydroxyurea, bone marrow transplant) are in trials at this time to see if risk of stroke and other neurologic complications can be reduced (ClinicalTrials.gov identifiers: NCT01425307, NCT01389024, NCT00152113).

Style APA, Harvard, Vancouver, ISO itp.

46

LaPierre, Yvette. Handling Sickle Cell Disease. ABDO Publishing Company, 2021.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

47

Sickle Cell Disease Patient. Tettah-A'Domeno Co, 1998.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

48

Bloom, Miriam. Understanding Sickle Cell Disease. University Press of Mississippi, 1995.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

49

Lapierre, Yvette. Handling Sickle Cell Disease. Essential Library, 2021.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

50

GLADWIN. Sickle Cell Disease (ie). McGraw-Hill Education, 2021.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!